Oculis Holding AG SEC filings OCSAW
Oculis Holding AG has 138 filings in SEC EDGAR's recent list, going back to Nov 7, 2022. Its latest annual report, Form 20-F, was filed on Mar 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | May 29, 2026 |
| 6-K | Current report (foreign issuer) | May 14, 2026 | May 14, 2026 |
| 6-K | Current report (foreign issuer) | May 11, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Apr 21, 2026 | Apr 21, 2026 |
| 6-K | Current report (foreign issuer) | Mar 4, 2026 | Mar 4, 2026 |
| 6-K | Current report (foreign issuer) | Mar 3, 2026 | Mar 3, 2026 |
| 6-K | Current report (foreign issuer) | Nov 10, 2025 | Nov 10, 2025 |
| 6-K | Current report (foreign issuer) | Oct 31, 2025 | Oct 31, 2025 |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 6-K | Current report (foreign issuer) | Oct 6, 2025 | Oct 6, 2025 |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| 6-K | Current report (foreign issuer) | Jun 5, 2025 | Jun 5, 2025 |
| 6-K | Current report (foreign issuer) | May 9, 2025 | May 9, 2025 |
| 6-K | Current report (foreign issuer) | May 8, 2025 | May 8, 2025 |
| 6-K | Current report (foreign issuer) | Apr 15, 2025 | Apr 15, 2025 |
| 6-K | Current report (foreign issuer) | Mar 11, 2025 | Mar 11, 2025 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Feb 14, 2025 |
| 6-K | Current report (foreign issuer) | Jan 6, 2025 | Jan 6, 2025 |
| 6-K | Current report (foreign issuer) | Nov 29, 2024 | Nov 29, 2024 |
| 6-K | Current report (foreign issuer) | Nov 7, 2024 | Nov 7, 2024 |
| 6-K | Current report (foreign issuer) | Aug 27, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 10, 2024 | Jun 10, 2024 |
| 6-K | Current report (foreign issuer) | May 31, 2024 | May 31, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 29, 2024 | Apr 29, 2024 |
| 6-K | Current report (foreign issuer) | Apr 22, 2024 | Apr 22, 2024 |
| 6-K | Current report (foreign issuer) | Apr 11, 2024 | Apr 11, 2024 |
| 6-K | Current report (foreign issuer) | Mar 19, 2024 | Mar 19, 2024 |
| 6-K | Current report (foreign issuer) | Feb 28, 2024 | Feb 28, 2024 |
| 6-K | Current report (foreign issuer) | Nov 15, 2023 | Nov 15, 2023 |
| 6-K | Current report (foreign issuer) | Aug 29, 2023 | Aug 29, 2023 |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Jul 12, 2023 | Jul 12, 2023 |
| 6-K | Current report (foreign issuer) | Jul 6, 2023 | Jul 6, 2023 |
| 6-K | Current report (foreign issuer) | Jun 13, 2023 | Jun 13, 2023 |
| 6-K | Current report (foreign issuer) | Jun 1, 2023 | Jun 1, 2023 |
| 6-K | Current report (foreign issuer) | May 30, 2023 | May 30, 2023 |
| 6-K | Current report (foreign issuer) | May 23, 2023 | May 22, 2023 |
| 6-K | Current report (foreign issuer) | Apr 14, 2023 | Apr 13, 2023 |
| 6-K | Current report (foreign issuer) | Mar 3, 2023 | Mar 3, 2023 |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OCS (Nasdaq), OCSAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1953530
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.